Product type number as specified by the Swiss Structured Products Association (SSPA): 1300
Please consult the termsheet and the accompanying issue prospectus for information on the exact product functionality, product details and risks.
| Scenario 1 | Scenario 2 | Scenario 3 | |
|---|---|---|---|
| Description | Rising underlying | Stagnating underlying | Falling underlying |
| Underlying value | 20% share A 20% share B 20% share C 20% D 20% share E |
20% share A 20% share B 20% share C 20% share D 20% share E |
20% share A 20% share B 20% share C 20% share D 20% share E |
| Term | 5 years | 5 years | 5 years |
| Issue price | CHF 100 | CHF 100 | CHF 100 |
| Capital employed | CHF 10'000 (100 Zertifikate) | CHF 10'000 (100 Zertifikate) | CHF 10'000 (100 Zertifikate) |
| Basket at initial fixing | CHF 100 | CHF 100 | CHF 100 |
| Basket at maturity | CHF 120 | CHF 100 | CHF 80 |
| Performance basket | 20% | 0% | -20% |
| Scenario 1 | Scenario 2 | Scenario 3 | |
|---|---|---|---|
| Calculation | 100 Zertifikate * 120 | 100 Zertifikate * 100 | 100 Zertifikate * 80 |
| Redemption | CHF 12'000 | CHF 10'000 | CHF 8'000 |
| Profit / Loss | 20% | 0% | -20% |
| ZKB Barrier Reverse Convertible on worst of Moderna Inc/BioNTech SE 139434101 / CH1394341015 |
| ZKB Callable Barrier Reverse Convertible on worst of Sonova Holding AG/Alcon AG/Straumann Holding AG... 140251442 / CH1402514421 |
| ZKB Reverse Convertible auf Moderna Inc 144653131 / CH1446531316 |
| ZKB Tracker-Zertifikat auf Aktienbasket Wasserstofftechnologie 56679191 / CH0566791916 |
| ZKB Barrier Reverse Convertible on worst of Novartis AG/Roche Holding AG/Alcon AG 139433744 / CH1394337443 |